Related Experiment Video
Updated: Sep 9, 2025
13:08
Measurement of Factor V Activity in Human Plasma Using a Microplate Coagulation Assay
Published on: September 9, 2012
19.1K
[Disseminated intravascular coagulation associated with hematologic malignancies]
1Department of Hematology, Fukushima Medical University School of Medicine.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology
|September 3, 2025
Summary
Managing disseminated intravascular coagulation (DIC) in hematological malignancies requires careful consideration of bleeding risks. Current treatments like thrombomodulin and antithrombin are preferred over heparinoids, but evidence is limited.
Area of Science:
- Hematology
- Oncology
- Coagulation Disorders
Background:
- Hematological malignancies frequently complicate with disseminated intravascular coagulation (DIC).
- Bleeding symptoms in malignancy-associated DIC are exacerbated by fibrinolysis and thrombocytopenia.
- Management of DIC in these patients presents significant clinical challenges due to bleeding risks.
Purpose of the Study:
- To review the complexities of managing disseminated intravascular coagulation (DIC) in patients with hematological malignancies.
- To discuss current therapeutic strategies and their limitations.
- To highlight areas for future research in optimizing DIC treatment.
Main Methods:
- Review of current literature on DIC in hematological malignancies.
- Analysis of pathophysiology, diagnostic criteria, and therapeutic options.
- Discussion of risks and benefits associated with different treatments.
Main Results:
- Antithrombotic therapy with heparinoids carries a high risk of bleeding complications.
- Thrombomodulin and antithrombin are preferred treatments but lack strong evidence.
- Early diagnosis and individualized treatment selection are crucial.
Conclusions:
- Effective management of DIC in hematological malignancies necessitates early diagnosis and understanding of pathophysiology.
- Treatment selection must balance benefits against the significant bleeding risks.
- Further research is needed on replacement therapy and optimal treatment thresholds.
Related Concept Videos
01:24Disorders of Hemostasis
1.2K
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
1.2K
01:29Venous Thrombosis III: Interprofessional Care
22
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
22
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
889
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
889
01:30Venous Thrombosis I: Introduction
40
Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...
40
01:20Extrinsic and Intrinsic Pathways of Hemostasis
9.2K
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
9.2K
01:25Immunodeficiency Diseases
1.2K
Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency...
There are three main causes of immunodeficiency...
1.2K